Merck Stops Developing Both Of Its COVID-19 Vaccine Candidates
Merck, which previously made an Ebola vaccine, had been seen as a serious contender in the worldwide race to come up with an answer to the coronavirus.
Merck is halting development of its two COVID-19 vaccine candidates, saying that while the drugs seemed to be safe, they didn't generate enough of an immune response to effectively protect people against the coronavirus.
Results ofabout its decision.
